HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maja Cemazar Selected Research

Interleukin-12 (IL 12)

2/2022Maintenance and gene electrotransfer efficiency of antibiotic resistance gene-free plasmids encoding mouse, canine and human interleukin-12 orthologues.
1/2022Treatment of skin tumors with intratumoral interleukin 12 gene electrotransfer in the head and neck region: a first-in-human clinical trial protocol.
10/2021Non-Clinical In Vitro Evaluation of Antibiotic Resistance Gene-Free Plasmids Encoding Human or Murine IL-12 Intended for First-in-Human Clinical Study.
10/2021Potentiation of electrochemotherapy effectiveness by immunostimulation with IL-12 gene electrotransfer in mice is dependent on tumor immune status.
1/2021Results of Dynamic Contrast-Enhanced Ultrasound Correlate With Treatment Outcome in Canine Neoplasia Treated With Electrochemotherapy and Interleukin-12 Plasmid Electrotransfer.
1/2021Tumor perfusion evaluation using dynamic contrast-enhanced ultrasound after electrochemotherapy and IL-12 plasmid electrotransfer in murine melanoma.
3/2020Intratumoral Gene Electrotransfer of Plasmid DNA Encoding shRNA against Melanoma Cell Adhesion Molecule Radiosensitizes Tumors by Antivascular Effects and Activation of an Immune Response.
3/2020Development of Tumor Cell-Based Vaccine with IL-12 Gene Electrotransfer as Adjuvant.
1/2019Intradermal DNA vaccination combined with dual CTLA-4 and PD-1 blockade provides robust tumor immunity in murine melanoma.
10/2018Antitumor effect of antibiotic resistance gene-free plasmids encoding interleukin-12 in canine melanoma model.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maja Cemazar Research Topics

Disease

99Neoplasms (Cancer)
02/2022 - 04/2002
42Melanoma (Melanoma, Malignant)
12/2021 - 04/2002
14Neoplasm Metastasis (Metastasis)
08/2021 - 06/2007
11Carcinoma (Carcinomatosis)
10/2021 - 04/2002
11Sarcoma (Soft Tissue Sarcoma)
09/2017 - 04/2002
10Breast Neoplasms (Breast Cancer)
11/2021 - 07/2004
8Necrosis
03/2020 - 07/2004
8Fibrosarcoma
04/2018 - 02/2003
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2021 - 04/2014
5Adenocarcinoma
04/2018 - 12/2009
4Hepatocellular Carcinoma (Hepatoma)
03/2022 - 03/2010
3Hypoxia (Hypoxemia)
03/2020 - 09/2005
3Hemorrhage
08/2012 - 05/2009
2Squamous Cell Carcinoma of Head and Neck
01/2022 - 10/2018
2Triple Negative Breast Neoplasms
08/2021 - 01/2020
2Infections
11/2019 - 01/2018
2Carcinogenesis
01/2018 - 08/2009
2Experimental Melanoma
12/2015 - 01/2012
1Colonic Neoplasms (Colon Cancer)
02/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2022
1Circulating Neoplastic Cells
10/2021
1Bites and Stings (Sting)
03/2021
1Lipid Metabolism Disorders (Metabolism Disorders, Lipid)
01/2021
1Hemangiosarcoma (Angiosarcoma)
12/2020
1Angiosarcoma of the breast
12/2020
1Papillomavirus Infections
01/2020
1B-Cell Lymphoma (Lymphoma, B Cell)
05/2019
1Prostatic Neoplasms (Prostate Cancer)
01/2019
1Glioma (Gliomas)
11/2018

Drug/Important Bio-Agent (IBA)

32DNA (Deoxyribonucleic Acid)IBA
01/2022 - 04/2002
29Bleomycin (Blenoxane)FDA LinkGeneric
01/2022 - 05/2004
27Interleukin-12 (IL 12)IBA
02/2022 - 11/2009
27Cisplatin (Platino)FDA LinkGeneric
01/2022 - 07/2002
12CytokinesIBA
02/2022 - 12/2007
9Pharmaceutical PreparationsIBA
02/2022 - 05/2009
8Small Interfering RNA (siRNA)IBA
03/2020 - 01/2013
8Green Fluorescent ProteinsIBA
05/2014 - 04/2002
7Proteins (Proteins, Gene)FDA Link
01/2020 - 06/2012
7PlatinumIBA
01/2020 - 07/2002
7EndoglinIBA
03/2017 - 01/2013
5Messenger RNA (mRNA)IBA
11/2021 - 01/2013
5Biological ProductsIBA
10/2021 - 03/2011
5Radiation-Sensitizing AgentsIBA
01/2021 - 01/2003
4EnzymesIBA
02/2022 - 01/2012
4CD146 AntigenIBA
12/2021 - 10/2014
4LuciferasesIBA
01/2016 - 01/2006
3Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2021 - 02/2018
3Immune Checkpoint InhibitorsIBA
08/2021 - 01/2019
3Nucleic AcidsIBA
11/2019 - 06/2012
3Peptides (Polypeptides)IBA
05/2015 - 09/2013
3Vinblastine (Vinblastine Sulfate)FDA Link
07/2014 - 07/2002
3Oxygen (Dioxygen)IBA
05/2010 - 05/2004
2Azacitidine (5 Azacytidine)FDA Link
03/2022 - 02/2011
2Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2021 - 08/2021
2olaparibIBA
10/2021 - 08/2021
2Biomarkers (Surrogate Marker)IBA
10/2021 - 01/2019
2AntigensIBA
03/2020 - 03/2017
2OvalbuminIBA
01/2019 - 04/2017
2Pattern Recognition ReceptorsIBA
04/2018 - 01/2018
2CollagenIBA
01/2017 - 01/2012
2Therapeutic UsesIBA
12/2015 - 11/2013
2Transforming Growth Factors (Transforming Growth Factor)IBA
05/2015 - 01/2013
2Endothelin-1 (Endothelin 1)IBA
05/2015 - 10/2013
2IntegrinsIBA
11/2013 - 04/2002
21-aminomethylphosphonic acidIBA
11/2013 - 09/2013
1Monoacylglycerol LipasesIBA
02/2022
1Sunitinib (Sutent)FDA Link
01/2022
1Glucose (Dextrose)FDA LinkGeneric
11/2021
1HexokinaseIBA
11/2021
1pembrolizumabIBA
08/2021
1Neoplasm Antigens (Tumor Antigens)IBA
08/2021
13-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA
01/2021
1Simvastatin (Zocor)FDA LinkGeneric
01/2021
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021
1Oxidoreductases (Dehydrogenase)IBA
01/2021
1CholesterolIBA
01/2021
1Cancer VaccinesIBA
03/2020
1VaccinesIBA
03/2020
1Blood Proteins (Serum Proteins)IBA
01/2020
1AnionsIBA
01/2020
1Hormones (Hormone)IBA
01/2020
1Carboplatin (JM8)FDA LinkGeneric
01/2020
12-diethylaminoethanol (DEAE)IBA
01/2020
1diethylamineIBA
01/2020
1Interferon Type IIBA
11/2019
1Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
05/2019
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
03/2019
1Melanoma-Specific AntigensIBA
01/2019
1DNA VaccinesIBA
01/2019

Therapy/Procedure

49Therapeutics
01/2022 - 05/2004
11Radiotherapy
12/2021 - 05/2004
8Electrodes (Electrode)
10/2019 - 05/2009
6Drug Therapy (Chemotherapy)
01/2020 - 05/2004
5Immunotherapy
02/2022 - 01/2017
4Aftercare (After-Treatment)
01/2020 - 09/2006
2Mastectomy (Mammectomy)
12/2020 - 08/2012
2Adjuvant Radiotherapy
12/2020 - 07/2010
1Free Tissue Flaps
12/2020
1Mammaplasty (Breast Reconstruction)
12/2020
1Neoadjuvant Therapy
01/2020